OF HYPOKALEMIC PERIODIC PARALYSIS AS AN INITIAL MANIFESTATION OF THYROTOXICOSIS: CASE REPORT AND LITERATURE REVIEW

Authors

  • Carolina Vitoratto Grunewald Author
  • Cezar Arruda de O. Filho Author
  • Laura Madureira Belíssimo Author
  • Bruno Conde Marques Author
  • Ewelyn Regina de Souza Author
  • Felipe Ribeiro Furlan Author
  • Maria Júlia Busnardo Aguena Author

DOI:

https://doi.org/10.56238/arev7n8-133

Keywords:

Periodic Paralysis, Hypokalemia, Thyrotoxicosis, Graves' Disease, Muscle Weakness

Abstract

Introduction: Hypokalemic periodic paralysis (HPP) secondary to thyrotoxicosis is a rare and potentially serious condition characterized by episodes of acute muscle weakness associated with hypokalemia in patients with hyperthyroidism. Although more common in Asian populations, it can affect individuals in other regions and is often underdiagnosed due to the absence of classic signs of thyrotoxicosis. (1,3,4) Case report: A healthy 18-year-old male patient presented with a sudden episode of pain followed by flaccid paralysis in both lower limbs, associated with tremors and tachycardia. Laboratory tests revealed severe hypokalemia and thyroid function suggestive of thyrotoxicosis. Doppler ultrasound of the thyroid revealed diffuse enlargement of the gland and increased peak systolic blood pressure in the arterial component, suggesting thyroid disease/glandular hyperfunction. Anti-TSH receptor antibody (TRAB) results were above normal, confirming the diagnosis of HPP secondary to Graves' disease. The patient received electrolyte correction, symptomatic management, and antithyroid medication (tapazole), with complete improvement in clinical status. Discussion: The pathophysiology of PPH is related to increased Na+/K+-ATPase pump activity induced by thyroid hormones, with consequent intracellular potassium shift. Early recognition and appropriate management of thyrotoxicosis are essential to prevent recurrences and complications.(1,8,9) Conclusion: This case reinforces the importance of considering thyrotoxicosis as an etiology of flaccid paralysis in patients with hypokalemia, especially in the absence of obvious secondary causes.

Downloads

Download data is not yet available.

References

LAM, L.; NAIR, R. J.; TINGLE, L. Thyrotoxic periodic paralysis. Baylor University Medical Center Proceedings, v. 19, n. 2, p. 126–129, abr. 2006. DOI: https://doi.org/10.1080/08998280.2006.11928143

LIN, S.-H. Thyrotoxic periodic paralysis. Mayo Clinic Proceedings, v. 80, n. 1, p. 99–105, jan. 2005. DOI: https://doi.org/10.4065/80.1.99

MANOUKIAN, M. A.; FOOTE, J. A.; CRAPO, L. M. Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes. Archives of Internal Medicine, v. 159, n. 6, p. 601–601, 22 mar. 1999. DOI: https://doi.org/10.1001/archinte.159.6.601

OBER, K. P. Thyrotoxic periodic paralysis in the United States: report of 7 cases and review of the literature. Medicine, v. 71, n. 3, p. 109–120, maio 1992. DOI: https://doi.org/10.1097/00005792-199205000-00001

KUNG, A. W. C. Thyrotoxic periodic paralysis: a diagnostic challenge. The Journal of Clinical Endocrinology & Metabolism, v. 91, n. 7, p. 2490–2495, jul. 2006. DOI: https://doi.org/10.1210/jc.2006-0356

PHUYAL, P.; NAGALLI, S. Hypokalemic periodic paralysis. Disponível em: https://www.ncbi.nlm.nih.gov/books/NBK559178/. Acesso em: 13 ago. 2025.

VIJAYAKUMAR, A.; ASHWATH, G.; THIMMAPPA, D. Thyrotoxic periodic paralysis: clinical challenges. Journal of Thyroid Research, v. 2014, p. 1–6, 2014. DOI: https://doi.org/10.1155/2014/649502

RYAN, D. P. et al. Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. Cell, v. 140, n. 1, p. 88–98, jan. 2010. DOI: https://doi.org/10.1016/j.cell.2009.12.024

STEDWELL, R. E.; ALLEN, K. M.; BINDER, L. S. Hypokalemic paralyses: a review of the etiologies, pathophysiology, presentation, and therapy. The American Journal of Emergency Medicine, v. 10, n. 2, p. 143–148, mar. 1992. DOI: https://doi.org/10.1016/0735-6757(92)90048-3

CHANG, C.-C. et al. A 10-year analysis of thyrotoxic periodic paralysis in 135 patients: focus on symptomatology and precipitants. European Journal of Endocrinology, v. 169, n. 5, p. 529–536, nov. 2013. DOI: https://doi.org/10.1530/EJE-13-0381

LIN, S.-H. Hypokalaemia and paralysis. QJM, v. 94, n. 3, p. 133–139, mar. 2001. DOI: https://doi.org/10.1093/qjmed/94.3.133

MESEEHA, M. et al. Thyrotoxic periodic paralysis: a case study and review of the literature. Journal of Community Hospital Internal Medicine Perspectives, v. 7, n. 2, p. 103–106, abr. 2017. DOI: https://doi.org/10.1080/20009666.2017.1316906

LU, K. et al. Effects of potassium supplementation on the recovery of thyrotoxic periodic paralysis. American Journal of Emergency Medicine, v. 22, n. 7, p. 544–547, nov. 2004. DOI: https://doi.org/10.1016/j.ajem.2004.09.016

KELLEY, D. E. et al. Thyrotoxic periodic paralysis: report of 10 cases and review of electromyographic findings. Archives of Internal Medicine, v. 149, n. 11, p. 2597–2600, nov. 1989. DOI: https://doi.org/10.1001/archinte.1989.00390110139031

Published

2025-08-14

Issue

Section

Articles

How to Cite

GRUNEWALD, Carolina Vitoratto; FILHO, Cezar Arruda de O.; BELÍSSIMO, Laura Madureira; MARQUES, Bruno Conde; DE SOUZA, Ewelyn Regina; FURLAN, Felipe Ribeiro; AGUENA, Maria Júlia Busnardo. OF HYPOKALEMIC PERIODIC PARALYSIS AS AN INITIAL MANIFESTATION OF THYROTOXICOSIS: CASE REPORT AND LITERATURE REVIEW. ARACÊ , [S. l.], v. 7, n. 8, p. e7314, 2025. DOI: 10.56238/arev7n8-133. Disponível em: https://periodicos.newsciencepubl.com/arace/article/view/7314. Acesso em: 5 dec. 2025.